CARRIE RADFORD: Open Payments
NPI 1679190136 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,003 in 41 payments from 10 companies in 2025. Trend: 2023 $270 · 2024 $657 · 2025 $1,003
Food & beverage: $1,003
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $231 |
| Regeneron Healthcare Solutions, Inc. | 9 | $224 |
| Genentech USA, Inc. | 7 | $153 |
| GlaxoSmithKline, LLC. | 6 | $124 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Optinose US, Inc. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Blueprint Medicines Corporation | 1 | $33 |
| Incyte Corporation | 1 | $17 |
Products named: DUPIXENT, Xolair, AIRSUPRA, NEFFY, TRELEGY ELLIPTA, FASENRA, NUCALA, CUVITRU.
Industry payments across VA — which companies pay providers there.
